To validate the analysis of lncRNAs profiles, we assessed the mRNA expression of BC087858 by qRT-PCR in different lung cancer cell lines and tissues from patients before EGFR TKIs treatment (BT group) and after harboring acquired resistance to TKIs (AR group). The gene discussed is EGFR; the disease is lung cancer.